Počet záznamů: 1  

Platelet-Rich Plasma in Temporomandibular Joint Osteoarthritis Therapy: A 3-Month Follow-Up Pilot Study

  1. 1.
    0426783 - FGÚ 2015 RIV US eng J - Článek v odborném periodiku
    Machoň, V. - Řehořová, M. - Šedý, Jiří - Foltán, R.
    Platelet-Rich Plasma in Temporomandibular Joint Osteoarthritis Therapy: A 3-Month Follow-Up Pilot Study.
    Journal of Arthritis. Roč. 2, č. 2 (2013), s. 100112. ISSN 2167-7921
    Institucionální podpora: RVO:67985823
    Klíčová slova: platelet-rich plasma * temporomandibular joint * osteoarthritis
    Kód oboru RIV: ED - Fyziologie

    The use of Platelet-Rich-Plasma (PRP) may provide a new and improved treatment option for early Temporomandibular Joint (TMJ) Osteoarthritis (OA). However, there are no studies on its use in TMJ arthritis in the literature. The present study compares 30 early onsets OA patients divided equally into 3 groups who had experienced no pain reduction following conservative and minimally invasive arthrocentesis and arthroscopy treatment. All patients had retrodiscitis and synovitis on arthroscopic examination and were without systemic joint disease, septic, or autoimmune arthritis. Only patients with unilateral TMJ symptoms were included in this study. Pain intensity was recorded for each patient using a 0-10 VAS scale. Maximum Interincisal Opening (MIO) was also recorded. This assessment was performed at the pretreatment and then at an examination 3 months after administration of 2 intra-articular applications of autologous PRP (Group A), 2 intra-articular injections of Hyaluronic Acid (HA) (Group B), or commencement of conservative therapy only with soft diet and analgetics (Group C). The results after 3 months revealed that intra-articular injection of autologous PRP appeared to be an effective treatment method for patients with early OA in this study. At the 3-month follow-up, patients from group A improved their mouth opening significantly. Majority of the PRP patients (Group A) showed decreased pain. The average pain score before PRP administration was 7, while 3 months after PRP administration the pain score was 3.5. In conclusion, the use of PRP is an effective treatment option for early TMJ OA
    Trvalý link: http://hdl.handle.net/11104/0239523

     
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.